About Saluda Medical
Saluda Medical is a private company based in Bloomington, Minnesota, incorporated in 2023 in Delaware. It has reported $179,999,347 raised in two offerings on Form D since April 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 30, 2025 | Nov 12, 2025 | $29,999,995fully sold | 26 | $1.1M | EquityRule 506(b) | Form D ↗ |
| Apr 6, 2023 | Apr 17, 2023 | $149,999,352fully sold | 18 | $8.3M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $179,999,347 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Saluda Medical's Form D filed Nov 12, 2025.
GP
Greg Plamondon
Executive officer
KC
Kristin Caplice
Chief Legal Officer and Secretary
JM
RF
Robert Faulkner
Director
DG
Doug Godshall
Director
GB
Geoffrey Brooke
Director
RP
Robert Palmisano
Director
BR
Barry Regan
Executive officer and director
CL
Catherine Livingstone
Director
CB
Chris Beare
Director
AC
Andrew Cleeland
Director
Earlier filings also listed Laureen DeBuono (director, last listed Apr 2023), James Schuermann (executive officer and director, last listed Apr 2023) and Geoffrey Kinghorn (director, last listed Apr 2023).